e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Nurses' involvement in the follow-up of patients with COPD and lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion
G. Bale, S. Burge, C. Burge, P. Martinez-Camblor, J. B. Soriano (Birmingham, United Kingdom; Bunyola, Illes Balears, Spain)
Source:
Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Session:
Nurses' involvement in the follow-up of patients with COPD and lung cancer
Session type:
Oral Presentation
Number:
1286
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bale, S. Burge, C. Burge, P. Martinez-Camblor, J. B. Soriano (Birmingham, United Kingdom; Bunyola, Illes Balears, Spain). Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion. Eur Respir J 2007; 30: Suppl. 51, 1286
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Reliability of cause-specific mortality adjudication in the TORCH clinical trial
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Chronic obstructive pulmonary disease (COPD), comorbid disease, and follow-up hospitalizations in a US cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Standardised mortality rates in females and males with COPD and asthma
Source: Eur Respir J 2005; 25: 891-895
Year: 2005
COPD coronary/peripheral vascular disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
COPD-related morbidity and mortality after smoking cessation: status of the evidence
Source: Eur Respir J 2008; 32: 844-853
Year: 2008
Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
Comorbid conditions reported in patients with COPD recruited into a global clinical trial (UPLIFT)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis
Source: Eur Respir J 2003; 22: 809-814
Year: 2003
Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Mortality figures for chronic obstructive pulmonary disease obtained from death certificates underestimate the true burden of disease; a five year retrospective analysis
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Developing COPD – a 25 year follow-up study of the general population
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006
Potential misclassification of causes of death from COPD
Source: Eur Respir J 2006 Oct 01;28(4):781-785
Year: 2006
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Haemoglobin level and its clinical impact in a cohort of patients with COPD
Source: Eur Respir J 2007; 29: 923-929
Year: 2007
The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept